P3 Health Partners Debt to Equity Ratio 2020-2024 | PIII

Current and historical debt to equity ratio values for P3 Health Partners (PIII) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. P3 Health Partners debt/equity for the three months ending December 31, 2024 was 1.18.
P3 Health Partners Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $0.71B $0.08B 9.32
2024-09-30 $0.71B $0.12B 5.92
2024-06-30 $0.73B $0.17B 4.35
2024-03-31 $0.71B $0.15B 4.84
2023-12-31 $0.72B $0.14B 5.06
2023-09-30 $0.71B $0.19B 3.77
2023-06-30 $1.05B $-0.14B -7.68
2023-03-31 $0.87B $0.00B -324.06
2022-12-31 $0.87B $0.01B 148.74
2022-09-30 $1.31B $0.08B 16.72
2022-06-30 $1.34B $0.11B 12.30
2022-03-31 $2.09B $0.26B 7.96
2021-12-31 $2.09B $0.27B 7.64
2021-09-30 $0.33B $-0.01B -31.92
2021-06-30 $0.31B $0.01B 62.42
2021-03-31 $0.00B $0.00B 0.00
2020-12-31 $0.00B 0.00
2019-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical MEDICAL INFO SYS $0.064B $1.500B
P3 Health Partners is a patient-centered and physician-led population health management company. P3 Health Partners, formerly known as Foresight Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) US $37.757B 52.15
Tempus AI (TEM) US $8.929B 0.00
Hims & Hers Health (HIMS) US $8.034B 129.14
Inspire Medical Systems (INSP) US $4.699B 91.27
IRhythm Technologies (IRTC) US $3.466B 0.00
Privia Health (PRVA) US $2.778B 208.18
Enovis (ENOV) US $1.976B 12.23
Schrodinger (SDGR) US $1.817B 0.00
Clover Health Investments (CLOV) US $1.696B 0.00
Phreesia (PHR) US $1.483B 0.00
Omnicell (OMCL) US $1.470B 31.70
Azenta (AZTA) US $1.199B 55.81
10x Genomics (TXG) US $0.991B 0.00
Butterfly Network (BFLY) US $0.568B 0.00
Fulgent Genetics (FLGT) US $0.532B 0.00
Talkspace (TALK) US $0.527B 313.00
Veradigm (MDRX) US $0.476B 0.00
Standard BioTools (LAB) US $0.422B 0.00
TruBridge (TBRG) US $0.390B 0.00
Claritev (CTEV) US $0.360B 0.00
Health Catalyst (HCAT) US $0.280B 0.00
Nyxoah SA (NYXH) BE $0.205B 0.00
SOPHiA GENETICS SA (SOPH) CH $0.201B 0.00
Pulmonx (LUNG) US $0.152B 0.00
American Well (AMWL) US $0.097B 0.00
EUDA Health Holdings (EUDA) SG $0.091B 0.00
Retrieve Medical Holdings (RMHI) US $0.085B 0.00
MDxHealth SA (MDXH) BE $0.082B 0.00
CareCloud (CCLD) US $0.075B 3.24
111 (YI) CN $0.071B 0.00
HeartBeam (BEAT) US $0.059B 0.00
Zepp Health (ZEPP) CN $0.041B 0.00
Outset Medical (OM) US $0.040B 0.00
Zhongchao (ZCMD) CN $0.029B 0.00
ImmunoPrecise Antibodies (IPA) CA $0.021B 0.00
Bullfrog AI Holdings (BFRG) US $0.017B 0.00
MSP Recovery (MSPR) US $0.016B 0.00
Streamline Health Solutions (STRM) US $0.013B 0.00
Healthcare Triangle (HCTI) US $0.012B 0.00
Strata Skin Sciences (SSKN) US $0.011B 0.00
Predictive Oncology (POAI) US $0.010B 0.00
Precipio (PRPO) US $0.010B 0.00
Movano (MOVE) US $0.006B 0.00
Mobile-health Network Solutions (MNDR) SG $0.004B 0.00
HeartSciences (HSCS) US $0.004B 0.00
Tivic Health Systems (TIVC) US $0.003B 0.00
Future Health ESG (FHLT) US $0.000B 0.00